The critical features and the mechanism of inhibition of a kinase interaction motif-based peptide inhibitor of JNK

被引:53
作者
Barr, RK
Boehm, I
Attwood, PV
Watt, PM
Bogoyevitch, MA
机构
[1] Univ Western Australia, Dept Biochem & Mol Biol, Crawley, WA 6009, Australia
[2] Univ Western Australia, Ctr Child Hlth Res, Crawley, WA 6009, Australia
[3] Western Australian Inst Med Res, Perth, WA 6000, Australia
关键词
D O I
10.1074/jbc.M402181200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We previously reported that a small peptide based on amino acids 143-153 of the c-Jun N-terminal kinase (JNK)-binding domain of JIP-1 functioned as an in vitro inhibitor of JNK activity. This peptide (TI-JIP: RP-KRPTTLNLF) resembles the kinase-interaction motif (KIM = (K/R)(2-3)X1-6(L/I)X(L/I)), which is common to upstream activators, downstream substrates, phosphatases, and scaffold proteins present in MAPK cascades. In this study, we characterized the mechanism of JNK inhibition by this peptide and further investigated the biochemical features of this peptide resulting in potent JNK inhibition. We also tested various KIM-based peptides for their ability to inhibit JNK activity. TI-JIP was found to be competitive with respect to the phosphoacceptor substrate c-Jun (K-I = 0.39 +/- 0.08 muM), and exhibit mixed (non-competitive) inhibition with respect to ATP. All seven substitutions of Pro-5 we tested significantly reduced the JNK inhibition, as did altering the Pro-5 to Leu-8 spacing. When we independently tested eight substitutions of either Thr-6 or Thr-7, only one substitution in each position was well tolerated. Furthermore, peptides based on the KIMs from other proteins were significantly less potent JNK inhibitors than TI-JIP, including a peptide from the JNK interactor Sab that contained all critical inhibitory residues present in TI-JIP. Therefore, despite having previously identified Arg-4, Pro-5, Leu-8, and Leu-10 in TI-JIP as independently critical for mediating JNK inhibition, we find their presence in other 11-mer peptides is not sufficient for JNK inhibition. TI-JIP is therefore a unique KIM-based inhibitor of JNK activity.
引用
收藏
页码:36327 / 36338
页数:12
相关论文
共 48 条
[1]   The specificities of protein kinase inhibitors: an update [J].
Bain, J ;
McLauchlan, H ;
Elliott, M ;
Cohen, P .
BIOCHEMICAL JOURNAL, 2003, 371 :199-204
[2]   Identification of the critical features of a small peptide inhibitor of JNK activity [J].
Barr, RK ;
Kendrick, TS ;
Bogoyevitch, MA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (13) :10987-10997
[3]   The c-Jun N-terminal protein kinase family of mitogen-activated protein kinases (JNK MAPKs) [J].
Barr, RK ;
Bogoyevitch, MA .
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2001, 33 (11) :1047-1063
[4]   SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase [J].
Bennett, BL ;
Sasaki, DT ;
Murray, BW ;
O'Leary, EC ;
Sakata, ST ;
Xu, WM ;
Leisten, JC ;
Motiwala, A ;
Pierce, S ;
Satoh, Y ;
Bhagwat, SS ;
Manning, AM ;
Anderson, DW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (24) :13681-13686
[5]   Inhibition of insulin receptor catalytic activity by the molecular adapter Grb14 [J].
Béréziat, V ;
Kasus-Jacobi, A ;
Perdereau, D ;
Cariou, B ;
Girard, J ;
Burnol, AF .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (07) :4845-4852
[6]  
BOGOYEVITCH MA, 1995, J BIOL CHEM, V270, P29710
[7]   Stimulation of the stress-activated mitogen-activated protein kinase subfamilies in perfused heart - p38/RK mitogen-activated protein kinases and c-Jun N-terminal kinases are activated by ischemia/reperfusion [J].
Bogoyevitch, MA ;
GillespieBrown, J ;
Ketterman, AJ ;
Fuller, SJ ;
BenLevy, R ;
Ashworth, A ;
Marshall, CJ ;
Sugden, PH .
CIRCULATION RESEARCH, 1996, 79 (02) :162-173
[8]   Cell-permeable peptide inhibitors of JNK novel blockers of β-cell death [J].
Bonny, C ;
Oberson, A ;
Negri, S ;
Sauser, C ;
Schorderet, DF .
DIABETES, 2001, 50 (01) :77-82
[9]   CEP-1347/KT7515, a JNK pathway inhibitor, supports the in vitro survival of chick embryonic neurons [J].
Borasio, GD ;
Horstmann, S ;
Anneser, JMH ;
Neff, NT ;
Glicksman, MA .
NEUROREPORT, 1998, 9 (07) :1435-1439
[10]   A peptide inhibitor of c-Jun N-terminal kinase protects against excitotoxicity and cerebral ischemia [J].
Borsello, T ;
Clarke, PGH ;
Hirt, L ;
Vercelli, A ;
Repici, M ;
Schorderet, DF ;
Bogousslavsky, J ;
Bonny, C .
NATURE MEDICINE, 2003, 9 (09) :1180-1186